IS6318A - Samvirkar samsetningar af NK1 viðtaka mótlyfi og GABA byggingarhliðstæður - Google Patents

Samvirkar samsetningar af NK1 viðtaka mótlyfi og GABA byggingarhliðstæður

Info

Publication number: IS6318A
Authority: IS; Iceland
Prior art keywords: receptor antagonists; structural analogs; synergistic combinations; gaba; gaba structural
Prior art date: 1999-10-07

Application number

IS6318A

Other languages

English (en)

Inventor

Hughes John

Singh Lakhbir

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-07

Filing date

2002-03-21

Publication date

2002-03-21

2002-03-21 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

2002-03-21 Publication of IS6318A publication Critical patent/IS6318A/is

Links

102000002002 Neurokinin-1 Receptors Human genes 0.000 title 1
108010040718 Neurokinin-1 Receptors Proteins 0.000 title 1
229960003692 gamma aminobutyric acid Drugs 0.000 title 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title 1
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1
239000011885 synergistic combination Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Addiction (AREA)
AIDS & HIV (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS6318A 1999-10-07 2002-03-21 Samvirkar samsetningar af NK1 viðtaka mótlyfi og GABA byggingarhliðstæður IS6318A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15827199P	1999-10-07	1999-10-07
PCT/EP2000/009858 WO2001024792A1 (en)	1999-10-07	2000-10-05	Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog

Publications (1)

Publication Number	Publication Date
IS6318A true IS6318A (is)	2002-03-21

Family

ID=22567369

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6318A IS6318A (is)	1999-10-07	2002-03-21	Samvirkar samsetningar af NK1 viðtaka mótlyfi og GABA byggingarhliðstæður

Country Status (38)

Country	Link
EP (2)	EP1221950B1 (is)
JP (2)	JP2003510356A (is)
KR (1)	KR20020060192A (is)
CN (1)	CN1387434A (is)
AP (1)	AP2002002501A0 (is)
AR (1)	AR029646A1 (is)
AT (1)	ATE269072T1 (is)
AU (2)	AU7663300A (is)
BG (1)	BG106548A (is)
BR (1)	BR0014598A (is)
CA (1)	CA2385930A1 (is)
CO (1)	CO5280195A1 (is)
CR (1)	CR6614A (is)
CZ (1)	CZ20021116A3 (is)
DE (1)	DE60011650T2 (is)
DK (1)	DK1221950T3 (is)
EA (1)	EA004266B1 (is)
EE (1)	EE200200185A (is)
ES (1)	ES2220542T3 (is)
GT (1)	GT200000166A (is)
HR (1)	HRP20020286A2 (is)
HU (1)	HUP0203466A3 (is)
IL (1)	IL148965A0 (is)
IS (1)	IS6318A (is)
MA (1)	MA26826A1 (is)
MX (1)	MXPA02003484A (is)
NO (1)	NO20021625D0 (is)
NZ (1)	NZ517949A (is)
OA (1)	OA12063A (is)
PA (1)	PA8504301A1 (is)
PE (1)	PE20010708A1 (is)
PL (1)	PL357498A1 (is)
PT (1)	PT1221950E (is)
SK (1)	SK4542002A3 (is)
TR (1)	TR200200913T2 (is)
UY (1)	UY26376A1 (is)
WO (2)	WO2001024792A1 (is)
ZA (1)	ZA200202675B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6001876A (en)	1996-07-24	1999-12-14	Warner-Lambert Company	Isobutylgaba and its derivatives for the treatment of pain
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
CN1662231A (zh) *	2002-04-24	2005-08-31	柏树生物科学公司	包括应激相关障碍在内的功能性躯体障碍的预防与治疗
US20060039968A1 (en) *	2002-10-08	2006-02-23	Ramalingam Manikandan	Gabapentin tablets and method for their preparation
WO2004084881A1 (en) *	2003-03-21	2004-10-07	Dynogen Pharmaceuticals, Inc.	METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
EP1492519B1 (en) *	2003-03-21	2006-11-15	Dynogen Pharmaceuticals, Inc.	Methods for treating lower urinary tract disorders using antimuscarinics and alpha-2-delta subunit calcium channel modulators
WO2004084880A1 (en) *	2003-03-21	2004-10-07	Dynogen Pharmaceuticals, Inc.	METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS
EP1543831A1 (en) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Pregabalin composition
DE102007019071A1 (de) *	2007-04-23	2008-10-30	Ratiopharm Gmbh	Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
MX2013000946A (es)	2010-07-30	2013-02-27	Toray Industries	Agente terapeutico o agente profilactico para el dolor neuropatico.
EP3753410A3 (en) *	2010-09-28	2021-04-28	The Regents Of The University Of California	Combinations comprising gaba agonists in treatment of hyperglycemia
ES3064256T3 (en) *	2019-03-26	2026-04-23	Orion Corp	Pregabalin formulations and use thereof
WO2022234110A1 (en) *	2021-05-07	2022-11-10	Plus Vitech, S.L.	Gamma-aminobutyric acid derivatives for use in cancer therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5025035A (en) *	1990-10-12	1991-06-18	Warner-Lambert Company	Method of treating depression
US5792796A (en) *	1994-07-27	1998-08-11	Warner-Lambert Company	Methods for treating anxiety and panic
US5510381A (en) *	1995-05-15	1996-04-23	Warner-Lambert Company	Method of treatment of mania and bipolar disorder
DE69736390T2 (de) *	1996-10-07	2007-07-26	Merck Sharp & Dohme Ltd., Hoddesdon	Zns-penetrierende nk-1 rezeptorantagonisten als antidepressivum und / oder anxiolytikum
WO1998024439A1 (en) *	1996-12-02	1998-06-11	Merck Sharp & Dohme Limited	Use of nk-1 receptor antagonists for treating severe anxiety disorders

2000
- 2000-01-05 AP APAP/P/2002/002501A patent/AP2002002501A0/en unknown
- 2000-10-05 DE DE60011650T patent/DE60011650T2/de not_active Expired - Fee Related
- 2000-10-05 DK DK00966138T patent/DK1221950T3/da active
- 2000-10-05 HU HU0203466A patent/HUP0203466A3/hu unknown
- 2000-10-05 MX MXPA02003484A patent/MXPA02003484A/es active IP Right Grant
- 2000-10-05 TR TR2002/00913T patent/TR200200913T2/xx unknown
- 2000-10-05 CZ CZ20021116A patent/CZ20021116A3/cs unknown
- 2000-10-05 BR BR0014598-0A patent/BR0014598A/pt not_active Application Discontinuation
- 2000-10-05 KR KR1020027004462A patent/KR20020060192A/ko not_active Withdrawn
- 2000-10-05 WO PCT/EP2000/009858 patent/WO2001024792A1/en not_active Ceased
- 2000-10-05 OA OA1200200107A patent/OA12063A/en unknown
- 2000-10-05 CA CA002385930A patent/CA2385930A1/en not_active Abandoned
- 2000-10-05 NZ NZ517949A patent/NZ517949A/en unknown
- 2000-10-05 EE EEP200200185A patent/EE200200185A/xx unknown
- 2000-10-05 AU AU76633/00A patent/AU7663300A/en not_active Abandoned
- 2000-10-05 ES ES00966138T patent/ES2220542T3/es not_active Expired - Lifetime
- 2000-10-05 CN CN00813906A patent/CN1387434A/zh active Pending
- 2000-10-05 SK SK454-2002A patent/SK4542002A3/sk unknown
- 2000-10-05 EP EP00966138A patent/EP1221950B1/en not_active Expired - Lifetime
- 2000-10-05 IL IL14896500A patent/IL148965A0/xx unknown
- 2000-10-05 AT AT00966138T patent/ATE269072T1/de not_active IP Right Cessation
- 2000-10-05 PT PT00966138T patent/PT1221950E/pt unknown
- 2000-10-05 JP JP2001527791A patent/JP2003510356A/ja not_active Withdrawn
- 2000-10-05 HR HR20020286A patent/HRP20020286A2/hr not_active Application Discontinuation
- 2000-10-05 PL PL00357498A patent/PL357498A1/xx not_active Application Discontinuation
- 2000-10-05 EA EA200200303A patent/EA004266B1/ru not_active IP Right Cessation
- 2000-10-06 GT GT200000166A patent/GT200000166A/es unknown
- 2000-10-06 CO CO00076105A patent/CO5280195A1/es not_active Application Discontinuation
- 2000-10-06 PE PE2000001069A patent/PE20010708A1/es not_active Application Discontinuation
- 2000-10-06 UY UY26376A patent/UY26376A1/es not_active Application Discontinuation
- 2000-10-06 AR ARP000105296A patent/AR029646A1/es not_active Application Discontinuation
- 2000-10-06 PA PA20008504301A patent/PA8504301A1/es unknown
- 2000-10-09 AU AU16962/01A patent/AU1696201A/en not_active Abandoned
- 2000-10-09 EP EP00979495A patent/EP1233766A1/en not_active Withdrawn
- 2000-10-09 WO PCT/EP2000/010084 patent/WO2001024791A1/en not_active Ceased
- 2000-10-09 JP JP2001527790A patent/JP2003510355A/ja not_active Withdrawn
2002
- 2002-03-21 IS IS6318A patent/IS6318A/is unknown
- 2002-03-22 BG BG106548A patent/BG106548A/xx unknown
- 2002-04-05 ZA ZA200202675A patent/ZA200202675B/xx unknown
- 2002-04-05 CR CR6614A patent/CR6614A/es not_active Application Discontinuation
- 2002-04-05 NO NO20021625A patent/NO20021625D0/no not_active Application Discontinuation
- 2002-04-05 MA MA26587A patent/MA26826A1/fr unknown

Also Published As

Publication number	Publication date
HRP20020286A2 (en)	2003-08-31
PT1221950E (pt)	2004-08-31
GT200000166A (es)	2002-03-30
CN1387434A (zh)	2002-12-25
CA2385930A1 (en)	2001-04-12
NO20021625L (no)	2002-04-05
CO5280195A1 (es)	2003-05-30
JP2003510356A (ja)	2003-03-18
WO2001024791A1 (en)	2001-04-12
JP2003510355A (ja)	2003-03-18
WO2001024792A9 (en)	2002-09-06
SK4542002A3 (en)	2003-09-11
AU7663300A (en)	2001-05-10
TR200200913T2 (tr)	2002-09-23
UY26376A1 (es)	2000-12-29
WO2001024792A1 (en)	2001-04-12
IL148965A0 (en)	2002-11-10
BG106548A (en)	2002-12-29
AR029646A1 (es)	2003-07-10
DE60011650T2 (de)	2005-07-14
PE20010708A1 (es)	2001-07-27
EE200200185A (et)	2003-04-15
ZA200202675B (en)	2003-04-15
AU1696201A (en)	2001-05-10
EP1221950B1 (en)	2004-06-16
EP1221950A1 (en)	2002-07-17
NZ517949A (en)	2003-08-29
EP1233766A1 (en)	2002-08-28
HUP0203466A3 (en)	2005-03-29
OA12063A (en)	2006-05-03
NO20021625D0 (no)	2002-04-05
AP2002002501A0 (en)	2002-06-30
MXPA02003484A (es)	2004-09-10
DK1221950T3 (da)	2004-09-20
ATE269072T1 (de)	2004-07-15
HUP0203466A2 (hu)	2003-02-28
CZ20021116A3 (cs)	2003-05-14
DE60011650D1 (de)	2004-07-22
EA004266B1 (ru)	2004-02-26
KR20020060192A (ko)	2002-07-16
CR6614A (es)	2003-12-04
PA8504301A1 (es)	2002-08-26
ES2220542T3 (es)	2004-12-16
BR0014598A (pt)	2002-06-11
MA26826A1 (fr)	2004-12-20
EA200200303A1 (ru)	2002-08-29
PL357498A1 (en)	2004-07-26

Publication	Publication Date	Title
NO20030471D0 (no)	2003-01-30	Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor
MA26762A1 (fr)	2004-12-20	Derives de pyrrolidine- antagonistes du recepteur ccr-3
NO20025640L (no)	2003-01-22	Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptorantagonister
IL153834A0 (en)	2003-07-31	N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
EE200300108A (et)	2005-02-15	Kondenseerunud heterotsüklilised suktsiinimiidiühendid ja nende analoogid kui tuuma hormooniretseptori funktsiooni modulaatorid
DK0968194T3 (da)	2004-08-16	Atropisomerer af 3-aryl-4(3H)-quinazolinoner og deres anvendelse som AMPA-receptor-antagonister
DK0733626T3 (da)	1999-08-09	N-(Benzofurazanyl)-arylsulfonamider og analoger deraf, der kan anvendes som endothelin-receptor-antagonister
DE69812602D1 (de)	2003-04-30	Antagonisten des vitronectin-rezeptors
DK1221950T3 (da)	2004-09-20	Synergitisk kombination af en NK1-receptorantagonist og en GABA-strukturanalog
DK1147075T3 (da)	2003-12-08	Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
ATE469875T1 (de)	2010-06-15	Nk1-antagonisten
ATE374183T1 (de)	2007-10-15	Nk1-antagonisten
DK0923550T3 (da)	2003-01-06	Acylaminoalkylen-amid-derivater som NK1- og NK2-antagonister
IT1313551B1 (it)	2002-09-09	Composizioni farmaceutiche disperdibili spontaneamente checontengono un antagonista della sostanza p costituito dalla
DK1073431T3 (da)	2004-10-04	Anvendelse af NMDA-antagonister til behandling af irritabel tarmsyndrom
NO20021113D0 (no)	2002-03-06	Vitronectin-reseptor-antagonister
DK1309607T3 (da)	2005-01-17	Fremgangsmåde til fremstilling af LHRH-antagonister
DK1237892T3 (da)	2003-08-04	Fremgangsmåde til fremstilling af epinastinhydrochlorid i den højtsmeltende krystalmodifikation
EP1223946A4 (en)	2003-05-07	HUMAN NEUROPEPTIDE RECEPTOR
EE200100214A (et)	2002-08-15	Ureidopiperidiini derivaadid kui inimese NK3 retseptorite selektiivsed antagonistid
DK1440067T3 (da)	2005-04-11	N-formyl-derivater af paroxetin
DK1173172T3 (da)	2006-05-15	Synergistiske virkninger af amlodipin og den hydroxylerede metabolit af atorvastatin
DK1131291T3 (da)	2005-02-28	4-aroyl-piperidin-CCR-3-receptorantagonister III
DK1313500T3 (da)	2005-02-14	Associationer af dalfopristin/quinupristin med cefpirom
DK1246828T3 (da)	2006-04-03	Benzosulfoner med calciummantagonist-aktivitet